We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Standard Life Aberdeen Plc | LSE:SLA | London | Ordinary Share | GB00BF8Q6K64 | ORD 13 61/63P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 274.10 | 273.20 | 273.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH TIDMSLA
RNS Number : 6103B
Dechra Pharmaceuticals PLC
21 September 2018
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)(i) 1a. Identity of the issuer or the Dechra Pharmaceuticals PLC underlying issuer of existing shares to which voting rights are attached: ------------------------------------------------ 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer ---- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights X ---- An acquisition or disposal of financial instruments ---- An event changing the breakdown of voting rights ---- Other (please specify)(iii) : ---- 3. Details of person subject to the notification obligation Name Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios City and country of registered office Edinburgh, Scotland (if applicable) 4. Full name of shareholder(s) (if different from 3.)(v) Name ------------------------------------------------ City and country of registered office (if applicable) ------------------------------------------------ 5. Date on which the threshold was 20/09/2018 crossed or reached(vi) : ------------------------------------------------ 6. Date on which issuer notified (DD/MM/YYYY): 21/09/2018 ------------------------------------------------ 7. Total positions of person(s) subject to the notification obligation % of voting % of voting rights Total of both Total number rights attached through financial in % (8.A + of voting rights to shares (total instruments 8.B) of issuer(vii) of 8. A) (total of 8.B 1 + 8.B 2) ------------------ ----------------------- ---------------- -------------------- Resulting situation on the date on which threshold was crossed or reached 8.23 0.03 8.26 102,329,635 ------------------ ----------------------- ---------------- -------------------- Position of previous notification (if applicable) 8.39 0.02 8.41 ------------------ ----------------------- ---------------- -------------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) A: Voting rights attached to shares Class/type of Number of voting rights(ix) % of voting rights shares ISIN code (if possible) Direct Indirect Direct Indirect (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive 2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.1) (DTR5.2.1) (DTR5.2.1) ----------------------------- GB0009633180 N/A 8,422,492 N/A 8.23 ------------------------ ----------------------------- ------------------------- --------------------- SUBTOTAL 8. A 8,422,492 8.23 ------------------------------------------------------- ------------------------------------------------ B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Type of Expiration Exercise/ Number of voting % of voting financial date(x) Conversion Period(xi) rights that may rights instrument be acquired if the instrument is Exercised/converted. ----------- ----------------------------------- -------------------------------- --------------------- Rights to recall lent shares 25,760 0.03 ----------- ----------------------------------- -------------------------------- --------------------- SUBTOTAL 8. B 1 25,760 0.03 ----------------------------------- -------------------------------- --------------------- B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Type of Expiration Exercise/ Physical or Number of % of voting financial date(x) Conversion cash voting rights rights instrument Period (xi) settlement(xii) ---------------- ---------------------- ----------------------- -------------------- SUBTOTAL 8.B.2 ----------------------- -------------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) Full chain of controlled undertakings through which the voting rights X and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) (please add additional rows as necessary) Name(xv) % of voting % of voting rights Total of both if rights if through financial it equals or is it equals instruments if it higher than the or is higher equals or is higher notifiable threshold than the than the notifiable notifiable threshold threshold --------------- --------------------- ------------------------ Standard Life Aberdeen plc --------------- --------------------- ------------------------ Standard Life Investments (Holdings) Limited --------------- --------------------- ------------------------ Standard Life Investments Limited --------------- --------------------- ------------------------ Standard Life Aberdeen plc --------------- --------------------- ------------------------ Aberdeen Asset Management PLC --------------- --------------------- ------------------------ Aberdeen Asset Investment Group Limited --------------- --------------------- ------------------------ Aberdeen Asset Investments Limited --------------- --------------------- ------------------------ Standard Life Aberdeen plc --------------- --------------------- ------------------------ Aberdeen Asset Management PLC --------------- --------------------- ------------------------ Aberdeen Asset Managers Limited --------------- --------------------- ------------------------ Standard Life Aberdeen plc
--------------- --------------------- ------------------------ Standard Life Investments (Holdings) Limited --------------- --------------------- ------------------------ Standard Life Wealth Limited --------------- --------------------- ------------------------ Standard Life Aberdeen plc --------------- --------------------- ------------------------ Standard Life Investments (Holdings) Limited --------------- --------------------- ------------------------ Ignis Asset Management Limited --------------- --------------------- ------------------------ Ignis Investment Services Limited --------------- --------------------- ------------------------ 10. In case of proxy voting, please identify: Name of the proxy holder N/A ----------------------------------------------- The number and % of voting rights N/A held ----------------------------------------------- The date until which the voting rights N/A will be held ----------------------------------------------- 11. Additional information(xvi) In reference to section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager. This disclosure is to reflect the fact that the voting rights effectively held indirectly by the underlying intermediate holding company Standard Life Investments (Holdings) Limited ("SLIHL") decreased below the 5% notifiable threshold due to trading on 20 September 2018. SLIHL now effectively holds the delegated voting rights to 4.92% of the shares in Dechra Pharmaceuticals PLC. Prior to this crossing, SLIHL effectively held 5.06% of the delegated voting rights. Place of completion Edinburgh, United Kingdom Date of completion 21/09/2018 -------------------------- Annex: Notification of major holdings (to be filed with the FCA only) A: Identity of the person subject to the notification obligation Full name (including legal form for legal entities) Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios ------------------------------------------- Contact address (registered office for legal entities) 1 George Street Edinburgh EH2 2LL ------------------------------------------- E-Mail ------------------------------------------- Phone number / Fax number ------------------------------------------- Other useful information (at least legal representative for legal persons) ------------------------------------------- B: Identity of the notifier, if applicable Full name Vikas Sharma ------------------------------------------- Contact address 1 George Street Edinburgh EH2 2LL ------------------------------------------- E-Mail Vikas. Sharma@aberdeenstandard.com ------------------------------------------- Phone number / Fax number +44 (0) 131 245 8562 ------------------------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------------- C: Additional information
Please send the completed form together with this annex to the FCA at the following email address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word format if possible.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLDMGZLKMFGRZM
(END) Dow Jones Newswires
September 21, 2018 11:45 ET (15:45 GMT)
1 Year Standard Life Aberdeen Chart |
1 Month Standard Life Aberdeen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions